MedPath

To compare .75% ropivacaine with dexmedetomidine and .75% ropivacaine with fentanyl undergoing infraumblical surgeries under spinal anesthesia

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/01/061586
Lead Sponsor
Jawahar Lal medical college ajmer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient belonging to ASA class 1 and 2 undergoing various infraumblical surgeries

Exclusion Criteria

Patient refusal uncooperative

Any known history of allergies

Local pathology at the site of injection

Bleeding disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the efficacy of intrathecal hyperbaric ropivacaine 0.75% with dexmedetomidine vs hyperbaric ropivacaine 0.75 with fentanyl in patient undergoing lower abdominal surgeries under spinal anaesthesia within baselineTimepoint: To assess the efficacy of intrathecal hyperbaric ropivacaine 0.75% with dexmedetomidine vs hyperbaric ropivacaine 0.75 with fentanyl in patient undergoing lower abdominal surgeries under spinal anaesthesia within baseline
Secondary Outcome Measures
NameTimeMethod
To assess the duration of sensory & motor block, compare hemodynamic Changes if any total rescue analgesia consumption at baselineTimepoint: Assess as grading point system <br/ ><br>At baseline , at 4week ,at 8 week
© Copyright 2025. All Rights Reserved by MedPath